In this issue:
Impact of COVID-19 isolation on patient burden of PD
Subthalamic nucleus stimulation in PD and brain morphology
Home-based VR training and telerehabilitation for balance
Neural correlates and predictors of subjective cognitive decline in PD
Levodopa threshold dosage for dyskinesia in PD
Safinamide as add-on therapy after STN-DBS for PD
Plasma neurofilament light chains and depressive and anxiety symptoms of PD
STN-DBS improves autonomic dysfunctions in PD
Imaging protein aggregates in serum and CSF in PD
Gender gap in DBS for PD
Please login below to download this issue (PDF)